MU
58
-4
FAST
48
2
V
58
2
DFS
57
-5
MRO
44
-6
ADT
35
-2
PG
43
2
AMG
41
-2
WMB
60
-3
MCHP
62
-2
VRTX
64
2
PCAR
48
-2
VIX
40
5
CA
36
12
CSCO
50
-3
CL
64
2
FIS
46
-2
BAC
57
-2
MAC
60
-4
APA
37
-5
MU
58
-4
FAST
48
2
V
58
2
DFS
57
-5
MRO
44
-6
ADT
35
-2
PG
43
2
AMG
41
-2
WMB
60
-3
MCHP
62
-2
VRTX
64
2
PCAR
48
-2
VIX
40
5
CA
36
12
CSCO
50
-3
CL
64
2
FIS
46
-2
BAC
57
-2
MAC
60
-4
APA
37
-5
Financhill
Back

Servisfirst Bancshares Vs. Viking Therapeutics Industry Stock Comparison

Sell
41

SFBS
Servisfirst Bancshares

Last Price:
60.91
Seasonality Move:
5.05%
Buy
54

VKTX
Viking Therapeutics

Last Price:
51.26
Seasonality Move:
6.26%
Sell
41
Servisfirst Bancshares (SFBS) is a Sell

Is Servisfirst Bancshares a Buy, Sell or Hold?

  • The current Servisfirst Bancshares [SFBS] share price is $60.92. The Score for SFBS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SFBS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $51.27. The Score for VKTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SFBS Stock Price Chart

What is Servisfirst Bancshares's stock price today?

  • The Servisfirst Bancshares share price today is $60.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SFBS is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $51.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

SFBS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 49.2 Sell
Chaikin Money Flow: -124649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.29 - 61.71) Buy
Bollinger Bands (100): (60.14 - 64.5) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.92 Sell
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -7165 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.73 - 57.75) Sell
Bollinger Bands (100): (49.81 - 78.71) Sell

SFBS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.29 Sell
20-day SMA: 60.45 Buy
50-day SMA: 61.8 Sell
200-day SMA: 59.39 Buy
8-day EMA: 61.36 Sell
20-day EMA: 61.04 Sell
50-day EMA: 61.46 Sell
200-day EMA: 60.54 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.94 Buy
20-day SMA: 52.11 Sell
50-day SMA: 62.69 Sell
200-day SMA: 39.93 Buy
8-day EMA: 51.54 Sell
20-day EMA: 53.48 Sell
50-day EMA: 58.29 Sell
200-day EMA: 45.95 Buy

Servisfirst Bancshares Earnings Growth & SFBS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.10 per share, and an increase next year of $0.47 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

Servisfirst Bancshares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):